Medivolve Inc MEDVF

Guru Strong Buy Recommendation! Very In depth!!

[MoneyGuy101]

https://www.tradingview.com/chart/QSC/pjXhzMW4-Strong-Buy-Recommendation-Guru/



**It is evident, Questcap intends to utilize its FDA approved antibody tests (1 of only 12 approved) for Covid 19 and implement its Standards to Safety to everyone. Advertising this "protocol" by using Hollywood and professional sports. All while, performing dozens of tests provided by QuestCaps affiliated companies. THIS IS A FULLY INTEGRATED COVID 19, ONE STOP SHOP that has FDA approval on a Extremely high demand product that is in short supply. Not only will Questcap produce 800,000 test kits a DAY but it will be used in the most lucrative markets (Canada, USA and Mexico). What I can't wrap my head around, How is this company only valued at less than 20 Million$ Canadian? Profit margins for these products are roughly 40% at say 20$ a kit @ 24 million kits per month = Revenue of 480 Million or 192 Million Max profit. Wishful thinking right? Well not exactly. You see, when testing for COVID 19 antibodies, especially in specific job or workplace environments, multiple tests are required. The number of tests per person, dependent could be as many as one antibody and 24 viral tests every 15 days, or 25 tests per 2 weeks for an entire year. Needless to say, Questcap is well on its well, with an initial conditional order of 1.5 million kits dependent on FDA approval, which it has received and that has not been announced yet. This is valued at 24 or 30 million$. Us/Cdn. So, their initial order, not yet disclosed, is currently worth more than their market cap. Not often you see this happen.

Technical-Trend- Fundamental Analysis -

BBW Showing 0.98 - Last time present was in 30th March 2020 prior to run up - Positive Bull Run Indicator
Sharp Buy Signal 28th July and 30th July.
MACD Shows strong Buy signal - Above 50 day and 200 day moving average.
Candlestick Prog. Range bound - .20-.30//.21-.285 - Break Out Above .285; Break Down Below .190 - No signal from Candlestick of Bearish Play.
Breakout evident on Timestamps for 15M, 30 Min, 1 -4 Hour
Sustained Continued Bull Run Nearing 1 Day; 1 Week Timestamp indicative of strong Bull Run.

**In my opinion, Two major buy signals with no inverted candlestick shows a strong buying opportunity at the current SP . Volume is substantially above average and most signals on the short and long term Fx are rated as a strong Buy.
Potential Downside: SP unable to Maintain high volume with increased SP for sustained growth. SP on lower range of Bullish Play. Selling pressure evident at high SP , neutral in line with 200 day moving average. Bear scenario .155 to .195
Overall: Charts are indicative of a major breakout likely to occur on or before the 17th of August. Stock likely to remain range bound until such time. While hugging the 200 and 50 day moving average in a bulllish manor. Range . 215 - .280; Until such time the sp breaks above with exponential growth. Selling pressure will mantain w/o news release until such time.
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Company Overview -Execution

1.) QuestCap Secures Exclusive Sales Rights for Emergency Use Authorized COVID-19 Lateral Flow Antibody Test Kit
The LYHER lateral flow test is one of only 12 lateral flow kits that have received Emergency Use Authorization.
The LYHER test kit was extensively reviewed by the US Food and Drug Administration (FDA) and the National Cancer Institute – Frederick National Laboratory and reported strong clinical results. The test kits are available for immediate sale in the United States.
As Covid-19 cases continue to surge, diagnostic test manufacturers and their suppliers are under unprecedented pressure.

2.) Lyher Covid-19 Daily production capacity 800,000 Kits
https://questcapinc.com/investor-presenta...

3.) QuestCap's Global Advisor Mike Tyson Implements The Standard for Safe Sport one antibody test and 24 viral tests every 15 days, for one year
established the COVID-19 Standard for Safe Sport, Industry, School, Film Set and Retail™ (the “Standard”), through which it is developing and implementing protocols to safely return sports players, business people, students, performers and shoppers to their respective professions and passions.
The Standard was adopted from standards and protocols originally developed for the professional and amateur sport’s industries entitled “The Standard for Safe Sports™” prepared by Glenco. This Standard has been presented to members of the NBA , MLB, CFL and the Dimayor league of Colombia.

4.)Lionsgate Implements Glenco's protocol "Standard for Safe Set one antibody test and 24 viral tests every 15 days, for one year
QuestCap Inc. (“QuestCap” or the “Company”) (CSE:QSC; FRA:34C1) is pleased to announce the use of Glenco’s Standard for Safe Sets (the “Standard”) by Pilgrim Media Group, a Lionsgate company based in North Hollywood, CA. In June, QuestCap acquired a 30% ownership in Glenco.

5.)Testing for COVID-19 antibodies. (INSIDE SALES)one antibody test and 24 viral tests every 15 days, for one year
Dr . Glenn Copeland, who also serves, as Director, Chairman and Chief Executive Officer of Glenco Medical. The Standard comprises medical screening protocols for individual health safety. The screenings will incorporate temperature and symptom checks in addition to serology testing for COVID-19 antibodies.

6.Testing for COVID-19 antibodies. (INSIDE SALES) one antibody test and 24 viral tests every 15 days, for one year
Colombian Full-Service Medical Clinic
Sanaty is creating a COVID-19 program that would be the only voluntary and prepaid annual diagnostic program in Colombia, that includes taking one antibody test and 24 viral tests every 15 days, for one year. Currently, no private prepaid health plan in Colombia offers anything similar. Sanaty is also looking to expand to other major cities in Colombia, including opening up four additional clinics in the next 12 months to reach additional patients.